STING1 and neoplasm: The HER2-AKT oncogenic pathway inhibits cGAS-STING pathway-mediated DNA immune recognition by suppressing STING-TBK1 interaction, as well as TBK1 K63-type ubiquitination, thereby inhibiting type I IFN production, cellular senescence, and apoptosis in tumor cells (52).